Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Li Zhi-Heng
Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells
PLoS ONE
Multidisciplinary
Related publications
The Effect of Food on the Bioavailability of Panobinostat, an Orally Active Pan-Histone Deacetylase Inhibitor, in Patients With Advanced Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Genistein Cooperates With the Histone Deacetylase Inhibitor Vorinostat to Induce Cell Death in Prostate Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Comparison of the Antifibrotic Effects of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-drug Pirfenidone in Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis
PLoS ONE
Multidisciplinary
The HDAC Inhibitor LBH589 (Panobinostat) Is an Inhibitory Modulator of Aromatase Gene Expression
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Histone Deacetylase Inhibitor Upregulates Peroxisomal Fatty Acid Oxidation and Inhibits Apoptotic Cell Death in Abcd1-Deficient Glial Cells
PLoS ONE
Multidisciplinary
Highly Effective Combination of LSD1 (KDM1A) Antagonist and Pan-Histone Deacetylase Inhibitor Against Human AML Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Gene Expression Profiling Induced by Histone Deacetylase Inhibitor, FK228, in Human Esophageal Squamous Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem Cells
Cancer Research
Cancer Research
Oncology
Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
